Correspondingly, PHF5A silencing prevented the growth of conventional patient-originated glioblastoma stem cell xenografts along with the in-vivo prohibition of glioblastoma stem cells tumor growth [31]. This evidence concerns the gene PHF5A and glioblastoma.